Biomedical Engineering Reference
In-Depth Information
TABLE 10.13: Empirical Power (%) at = 5% (two-sided): HR = 0.67,
60% Event Rate, 24 Weeks Median in C
Scenario
Interval
Right-point
Mid-point
Finkelstein's
Sun's
6
86.3
86.3
86.7
86.3
I
8
86.0
86.0
86.0
85.9
12
85.3
85.3
85.4
85.4
6
86.4
86.2
86.4
86.5
II
8
86.2
85.9
86.1
86.4
12
85.3
85.1
85.0
85.2
6
86.7
86.8
86.9
86.3
III
8
86.6
86.7
86.5
86.2
12
85.5
85.4
85.9
85.9
6
77.8
77.8
86.9
86.4
IV
8
72.5
72.5
86.8
86.2
12
59.9
59.9
86.0
85.5
6
92.9
92.9
86.7
86.1
V
8
94.7
94.7
86.9
85.9
12
97.1
97.1
86.1
85.2
Exactlogranktestpower86.9%.
10.4
Discussions and Recommendations
In this chapter, we compared different approaches to handle PFS data, for
example, conventional approaches and interval-censored methods, in terms of
both point estimation and hypothesis testing. The empirical performance of
these methods was evaluated by Monte Carlo simulations with sample sizes
commonly used in practice. In particular, we focused on the situations when
assessment schedules are equal (or intended to be equal) between treatment
arms, and compared scenarios, where potential bias may arise in practice
 
Search WWH ::




Custom Search